Forma Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2020
November 12, 2020 at 05:35 pm IST
Forma Therapeutics Holdings, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2020. For the quarter, the company reported loss from operations was $32,240,000 against $30,985,000 a year ago. Net loss was $27,616,000 against $30,985,000 a year ago. Diluted per share was $0.67.
For the nine months, the company reported loss from operations was $68,355,000 against $11,354,000 a year ago. Net loss was $41,826,000 against $10,137,000 a year ago. Diluted per share was $2.74.